Rigshospitalet - a highly specialised hospital in Denmark

Gå til hovedindhold

Skip to main content

News from Rigshospitalet

24. November 2021

Well-known drug could help the most severely affected Covid-19 patients in intensive-care departments

Damage to the body's most important organs is reduced significantly in mechanically ventilated patients with corona if they receive a medicine called prostacyclin. This is the result of a new study from Rigshospitalet.

23. November 2021

French intensive care physician receives this year's international KFJ Award

Professor Elie Azoulay has received Rigshospitalet's international KFJ Award for his ground-breaking research on some of the most seriously ill intensive care patients with blood cancer.

28. September 2021

Expert group: pregnant women should be wary of taking paracetamol

Pain-relieving medication with paracetamol should not be taken during pregnancy unless there are good medical reasons for doing so, and only at the lowest possible dosage.

26. August 2021

Scottish professor wins prestigious Danish research award

The International KFJ research award from Copenhagen University Hospital – Rigshospitalet goes to professor John McMurray from the University of Glasgow. The Scottish research heavyweight has been working with Danish heart failure researchers for more than a decade.

Men with testicular cancer stand a good chance of having children

A new study from Rigshospitalet shows that men with testicular cancer have a far better chance of obtaining fatherhood after treatment than previously assumed. In fact, statistically around half of all men who have undergone treatment for testicular cancer have the same chance of obtaining fatherhood as the rest of the male population.

A tiny gene mutation with a huge significance for male sperm production

New research from Rigshospitalet explains why some men produce no sperm cells at all, meaning that fertility treatment can never help them.

Researchers link drug with higher risk of tumours in the brain membrane

A new study from Rigshospitalet has demonstrated a link between the drug cyproterone acetate (Androcur®) and a type of brain tumour known as a meningioma. Among other things, the drug is used for male-to-female transgender hormone therapy.

Danish-Norwegian registry study on adverse reactions after AstraZeneca vaccination has now been published

In a Danish-Norwegian collaboration, researchers have shown a slightly increased rate of rare but serious types of cerebral blood clots as well as a generally increased rate of venous blood clots following vaccination with the AstraZeneca vaccine. The risk of such adverse events is considered very low for the individual vaccine recipient.

Research breakthrough provides hope for a new treatment for men with low sperm quality

Researchers at Rigshospitalet and Harvard University are the first in the world to prove that a drug against osteoporosis also increases the number of sperm cells in men with low sperm quality. There is hope the drug can be used in a new, promising treatment for men with low sperm quality.

New research: Considerably lower incidence of cervical cancer for young women vaccinated against HPV

A major Danish study has showed that the incidence of cervical cancer is up to 86% lower for women who received HPV vaccine before the age of 20. The researchers behind the study believe that it may be possible to almost eradicate cervical cancer in Denmark.

More news

Advice on coronavirus

Information in English and 9 lother anguages. Advice on visiting the hospital, as a patient or a relative, and what to do if you're experiencing symptoms.

Research

Research is one of the cornerstones of Rigshospitalet. This means that research occupies a very special place of importance and priority at Rigshospitalet.

Publishing date: 11/2/2021 11:48 AM